Skip to main content
. 2018 Jul 30;11(6):810–821. doi: 10.1093/ckj/sfy052

Table 1.

Prevalence of sarcopenia in CKD and associations with mortality and physical function

Reference Population Criteria Prevalence (%) Association
Souza et al. [17] NDD
  • EWGSOP

  • FNIH

  • 11.9

  • 28.7

ADL, gait speed, functional capacity, higher BMI
Zhou et al. [18] NDD CKD (Stages 3–5)
  • ASMI < 7.3/5.5 kg/m2 men/women

  • HGS < 30/20 kg men/women

  • ASMI and Handgrip

  • 36

  • 29

  • 14

Measured GFR, functional reach, Berg balance score.
Pereira et al. [10] NDD CKD (3–5)
  • HGS < 30th percentile of population, sex-specific reference, plus:

  • MACM < 90% population reference

  • SGA

  • BIA < 10.76/6.76 kg/m2 men/women

  • 9.8

  • 9.4

  • 5.9

Mortality HR (association between mortality and sarcopenia according to BIA significant after multivariate adjustment)
Lamarca et al. [19] HD CKD
  • DEXA 20th percentile of young individuals

  • 2 SD below mean of young individuals

  • BIA 20th percentile of young individuals

  • 2 SD below mean of young individuals

  • SKF 20th percentile of young individuals

  • 2 SD below mean of young individuals

  • MAMC < 90% population reference

  • CC <31 cm

  • HGS < 10th percentile of population cohort

  • 73.5

  • 32.7

  • 51

  • 13.7

  • 44.1

  • 3.9

  • 34.7

  • 21.8

  • 85.1

Kittiskulnam et al. [20] HD CKD
  • Low MM (2 SD below sex-specific means for young adults) indexed to:

  • Height

  • Weight

  • BSA

  • BMI

  • Low MM and SM strength (HGS <26/16 kg men/women) indexed to:

  • Height

  • Weight

  • BSA

  • BMI

  • 8.1

  • 25.3

  • 32.4

  • 25.0

  • 3.9

  • 11.4

  • 15.9

  • 14.0

Gait speed (Associations between data and mortality presented in another paper [21]. Significantly higher mortality rate in sarcopenic patients, according to low MM, but not in adjusted models)
Gracia-Iguacel et al. [22] HD CKD
  • ISRMN [23] criteria of PEW at 3 time points

  • Baseline

  • 12 months

  • 24 months

  • 37

  • 40.5

  • 41.1

No association between PEW and mortality but loss of MM associated with increased mortality
Carrero et al. [24] HD SGA 39 Mortality risk
Kittiskulnam et al. [21] HD HGS <26/16 kg men/women 29.9 Low HGS and slow gait speed associated with mortality risk
Chang et al. [25] NDD CKD HGS, SGA, BIA, MAMC, MAMA, MAC, SKF N/A Only HGS was significantly associated with composite endpoints of non-dialysis mortality and ESRD
Isoyama et al. [26] Dialysis CKD
  • ASMI 7.3/5.5 kg/m2

  • HGS <30/20 kg men/women

  • Combined

  • 24%

  • 15%

  • 20%

  • Low MS associated with PEW, comorbidities, inactivity, old age, low albumin, inflammation. No association of these factors with low MM

  • Both low MS and MM independently associated with mortality risk

Wang et al. [27] NDD CKD LTI <10% reference value 12.2% Serum albumin, eGFR, age, IL-6, CVD

ASMI, Appendicular Skeletal Muscle Index; BIA, bioelectrical impedance analysis; BSA, body surface area; CC, calf circumference; DEXA, dual-energy X-ray absorptiometry; SKF, skinfold thickness; HGS, handgrip strength; LTI, Lean Tissue Index.; MAC, mid-arm circumference; MAMA, mid-arm muscle area; MAMC, mid-arm muscle circumference; NDD, non-dialysis dependent; SGA, subjective global assessment; SM, skeletal muscle.